8-K

AMERICAN VANGUARD CORP (AVD)

8-K 2020-08-10 For: 2020-08-06
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): August 6, 2020

AMERICAN VANGUARD CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-13795 95-2588080
(State or other jurisdiction<br> <br>of incorporation) Commission<br> <br>File Number (I.R.S. Employer<br> <br>Identification No.)

4695 MacArthur Court

Newport Beach, California 92660

(Address of principal executive offices)

Registrant’s telephone number: (949) 260-1200

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading<br> <br>Symbol Exchanges<br> <br>on which registered
Common Stock, $.10 par value AVD New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b02 of the Securities Exchange Act of 1934 (§240.12b02 of this chapter).

Emerging Growth Company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02 Results of Operations and Financial Condition

On August 6, 2020, American Vanguard Corporation (“Registrant”) issued a press release announcing its financial results for the three and six months ended June 30, 2020. The full text of the press release is linked hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K, including the Exhibit linked hereto, is being furnished under Items 2.02 and 9.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Press release dated August 6, 2020 of Registrant regarding financial results for the three and six months ended June 30, 2020.
Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMERICAN VANGUARD CORPORATION
Date: August 10, 2020 By: /s/ Timothy J. Donnelly
Timothy J. Donnelly
Chief Administrative Officer, General Counsel<br> <br>& Secretary

EX-99.1

Exhibit 99.1

LOGO **** **** **** ****     ****

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS SECOND QUARTER AND MID-YEAR 2020 RESULTS

Newport Beach, CA – August 6, 2020 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the quarter and half-year ended June 30, 2020.

Financial Highlights Fiscal 2020 Second Quarter – versus Fiscal 2019 Second Quarter

Net sales of $105 million in 2020, compared with $113 million in 2019
Net income of $3.9 million in 2020, compared with $3.1 million in 2019
--- ---
Earnings per diluted share of $0.13 in 2020, compared with $0.11 in 2019
--- ---
EBITDA^1^ of $12.7 million in 2020, compared with<br>$11.9 million in 2019
--- ---

Financial Highlights Fiscal 2020 Six Months – versus Fiscal 2019 Six Months

Net sales of $201 million in 2020, compared with $213 million in 2019
Net income of $4.4 million in 2020, compared with $7 million in 2019
--- ---
Earnings per diluted share of $0.15 in 2020, compared with $0.24 in 2019
--- ---
EBITDA of $20.3 million in 2020, compared with $24.5 million in 2019
--- ---

Eric Wintemute, Chairman and CEO of American Vanguard commented, “During the quarter we recorded improved profitability on lower sales, in spite of pandemic-related effects on new product launches and reduced demand for crop commodities used by restaurants. In the face of market uncertainty, our team responded by maintaining operations without disruption, generating a profitable sales mix, improving manufacturing efficiency and reducing operating expenses in a disciplined fashion. Consequently, we have been able to generate a quarterly improvement in net income, earnings per share and EBITDA. In addition, we recorded lower working capital, improved net cash from operations by $32 million and thereby reduced debt, as compared to the same period in 2019.”

Mr. Wintemute continued, “In light of second quarter profitability and improvement of our balance sheet, I am encouraged by the direction of our financial performance during this unusual time. However, the year got off to a slow start. Thus, our first half results trailed those of the prior year with net sales down approximately 6% and higher operating expenses as a percent of net sales, due largely to a credit taken for deferred purchase price consideration in 2019. Gross margin remained flat at 39%, while factory performance was improved during the first half of 2020 versus that of 2019.”

^1^ Earnings before interest, taxes, depreciation and amortization. EBITDA is not a financial measure calculated<br>and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an<br>alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define<br>EBITDA differently.

Mr. Wintemute continued, “We are well-positioned to address our markets over the balance of 2020 and remain poised to perform in line with our peers. Factors that could materially affect our performance include our mosquito control business, which should benefit from forecasted hurricane activity expected to impact the South and Southeastern United States this summer, the strength of our soil fumigants, improved supply of Krovar^®^ and Hyvar^®^ herbicides, and growth of our corn and soybean franchises. At the same time, we will continue to pursue our key strategic initiatives for future growth, including the development and launch of new product formulations, further successful collaboration with respect to Proctor & Gamble’s Zevo^®^ product line, and the expanded full commercial launch of our SIMPAS^®^ precision application system later this year. We look forward to providing investors with additional information during our earnings conference call.”

Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele EVP & COO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 4:30 pm ET / 1:30 pm PT on Thursday, August 6, 2020. Interested parties may participate in the call by dialing (201) 493-6744 – please dial in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000^®^ and Russell 3000^®^ Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

Company Contact: Investor Representative
American Vanguard Corporation The Equity Group Inc.
William A. Kuser, Director of Investor Relations www.theequitygroup.com
(949) 260-1200 Lena Cati (212) 836-9611
williamk@amvac.com Lcati@equityny.com

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

ASSETS

December 31,<br>2019
Current assets:
Cash and cash equivalents 8,600 $ 6,581
Receivables:
Trade, net of allowance for doubtful accounts of 2,658 and 2,300, respectively 123,406 136,075
Other 9,324 16,949
Total receivables, net 132,730 153,024
Inventories, net 180,993 163,313
Prepaid expenses 12,502 10,457
Income taxes receivable 1,925 2,824
Total current assets 336,750 336,199
Property, plant and equipment, net 59,161 56,521
Operating lease<br>right-of-use assets 10,034 11,258
Intangible assets, net of amortization 194,357 198,377
Goodwill 41,278 46,557
Other assets 19,754 21,186
Total assets 661,334 $ 670,098
LIABILITIES AND STOCKHOLDERS’ EQUITY ****
Current liabilities:
Current installments of other liabilities 217 $ 1,513
Accounts payable 52,599 64,881
Deferred revenue 4,347 6,826
Accrued program costs 60,264 47,699
Accrued expenses and other payables 9,610 12,815
Operating lease liabilities, current 4,771 4,904
Total current liabilities 131,808 138,638
Long-term debt, net of deferred loan fees 159,407 148,766
Operating lease liabilities, long-term 5,419 6,503
Other liabilities, excluding current installments 10,595 12,890
Deferred income tax liabilities 14,445 19,145
Total liabilities 321,674 325,942
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, .10 par value per share; authorized 400,000 shares; none issued
Common stock, .10 par value per share; authorized 40,000,000 shares; issued 33,229,078 shares at<br>June 30, 2020 and 33,233,614 shares at December 31, 2019 3,324 3,324
Additional paid-in capital 90,994 90,572
Accumulated other comprehensive loss (14,437 ) (5,698 )
Retained earnings 277,939 274,118
357,820 362,316
Less treasury stock at cost, 3,061,040 shares at June 30, 2020 and<br>December 31, 2019 (18,160 ) (18,160 )
Total stockholders’ equity 339,660 344,156
Total liabilities and stockholders’ equity 661,334 $ 670,098

All values are in US Dollars.

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

For the Three Months<br>Ended June 30, For the Six Months<br>Ended June 30,
2020 2019 2020 2019
Net sales $ 104,555 $ 113,104 $ 200,517 $ 212,780
Cost of sales 64,249 71,451 121,830 129,425
Gross profit 40,306 41,653 78,687 83,355
Operating expenses 33,555 35,362 70,100 70,162
Operating income 6,751 6,291 8,587 13,193
Interest expense, net 1,274 1,925 2,782 3,537
Income before provision for income taxes and loss on equity method investment 5,477 4,366 5,805 9,656
Income tax expense 1,565 1,224 1,360 2,584
Income before loss on equity method investment 3,912 3,142 4,445 7,072
Loss from equity method investment 25 36 38 60
Net income attributable to American Vanguard $ 3,887 $ 3,106 $ 4,407 $ 7,012
Earnings per common share—basic $ .13 $ .11 $ .15 $ .24
Earnings per common share—assuming dilution $ .13 $ .11 $ .15 $ .24
Weighted average shares outstanding—basic 29,413 29,001 29,350 28,989
Weighted average shares outstanding—assuming dilution 29,854 29,540 29,904 29,560

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

ANALYSIS OF SALES

Forthe three and six months ended June 30, 2020 and 2019

(In thousands)

(Unaudited)

For the three months<br>ended June 30,
2020 2019 Change % Change
Net sales:
US crop $ 44,670 $ 47,575 $ (2,905 ) -6 %
US non-crop 13,872 16,955 (3,083 ) -18 %
US total 58,542 64,530 (5,988 ) -9 %
International 46,013 48,574 (2,561 ) -5 %
Net sales: $ 104,555 $ 113,104 $ (8,549 ) -8 %
Gross profit:
US crop $ 21,758 $ 18,719 $ 3,039 16 %
US non-crop 7,029 8,558 (1,529 ) -18 %
US total 28,787 27,277 1,510 6 %
International 11,519 14,376 (2,857 ) -20 %
Total gross profit: $ 40,306 $ 41,653 $ (1,347 ) -3 %
For the six months<br>ended June 30,
--- --- --- --- --- --- --- --- --- --- ---
2020 2019 Change % Change
Net sales:
US crop $ 95,032 $ 97,845 $ (2,813 ) -3 %
US non-crop 24,865 28,222 (3,357 ) -12 %
US total 119,897 126,067 (6,170 ) -5 %
International 80,620 86,713 (6,093 ) -7 %
Net sales: $ 200,517 $ 212,780 $ (12,263 ) -6 %
Gross profit:
US crop $ 46,003 $ 42,214 $ 3,789 9 %
US non-crop 11,748 14,872 (3,124 ) -21 %
US total 57,751 57,086 665 1 %
International 20,936 26,269 (5,333 ) -20 %
Total gross profit: $ 78,687 $ 83,355 $ (4,668 ) -6 %

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

For the Six Months Ended<br>June 30,
2020 2019
Cash flows from operating activities:
Net income $ 4,407 $ 7,012
Adjustments to reconcile net income to net cash provided by (used in) operating<br><br><br>activities:
Depreciation and amortization of property, plant and equipment and intangible assets 9,665 9,233
Amortization of other long-term assets and deferred loan fees 2,104 2,146
Amortization of discounted liabilities 7
Provision for bad debts 392 445
Revision of deferred consideration (2,888 )
Stock-based compensation 2,545 2,995
Change in deferred income taxes (1,562 ) (572 )
Loss from equity method investment 38 60
Net foreign currency adjustment 594 86
Changes in assets and liabilities associated with operations:
Decrease in net receivables 16,421 7,841
Increase in inventories (21,706 ) (27,635 )
Increase in prepaid expenses and other assets (2,297 ) (1,844 )
Increase in net operating lease liability 7 73
Decrease (increase) in income tax receivable 899 (4,480 )
Decrease in accounts payable (12,351 ) (10,224 )
Decrease in deferred revenue (2,431 ) (19,438 )
Increase in accrued program costs 12,577 11,823
Decrease in other payables and accrued expenses (3,621 ) (6,719 )
Net cash provided by (used in) operating activities 5,688 (32,086 )
Cash flows from investing activities:
Capital expenditures (6,386 ) (7,216 )
Acquisition of business, product lines, and intangible assets (3,889 ) (24,302 )
Investments (1,190 )
Net cash used in investing activities (11,465 ) (31,518 )
Cash flows from financing activities:
Net borrowings under line of credit agreement 10,502 67,800
Net payments from the issuance of common stock (sale of stock under ESPP,<br><br><br>exercise of stock options, and shares purchased for tax withholding) (2,123 ) (513 )
Repurchase of common stock (2,604 )
Payment of cash dividends (1,168 ) (1,160 )
Net cash provided by financing activities 7,211 63,523
Net increase (decrease) in cash and cash equivalents 1,434 (81 )
Effect of exchange rate changes on cash and cash equivalents 585 220
Cash and cash equivalents at beginning of period 6,581 6,168
Cash and cash equivalents at end of period $ 8,600 $ 6,307
Supplemental cash flow information:
Cash paid during the period for:
Interest $ 2,902 $ 3,339
Income taxes, net $ 1,901 $ 7,583

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA

For the three and six months June 30, 2020 and 2019

(Unaudited)

Three MonthsEnded June 30, Six MonthsEnded June 30,
2020 2019 2020 2019
Net income attributable to American Vanguard, as reported $ 3,887 $ 3,106 $ 4,407 $ 7,012
Provision for income taxes 1,565 1,224 1,360 2,584
Interest expense, net 1,274 1,925 2,782 3,537
Depreciation and amortization 5,981 5,688 11,769 11,379
EBITDA^2^ $ 12,707 $ 11,943 $ 20,318 $ 24,512
^2^ Earnings before interest, taxes, depreciation and amortization. EBITDA is not a financial measure calculated<br>and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measures so calculated and presented, nor as an<br>alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define<br>EBITDA differently.
--- ---